A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

Novo Nordisk's weight loss drug, Saxenda, helped children ages six to 11 reduce their body mass index in a recent trial.

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers ...

Anti-obesity medications (AOMs) such as GLP-1s will play an unquestionable long-term role in balancing the “food trilemma”.

Explore how peptide drugs are changing the hundred-billion-level weight loss market, and how this landscape is changing as ...

The latest generation of weight-loss drugs—the likes of Wegovy, Ozempic and Maunjaro from the stables of Novo Nordisk and ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

Interview with the Milanese immunologist Attilio Speciani. They call it an anti-obesity drug, but it's not just that: in ...

The growth of highly sought-after weight-loss drugs like Wegovy and Ozempic, otherwise known as GLP-1 medications, represents ...

Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...